Kajian syor campuran Pfizer, Astrazeneca berkesan
dc.contributor.author | Anon | |
dc.date.accessioned | 2021-07-01T07:12:15Z | |
dc.date.available | 2021-07-01T07:12:15Z | |
dc.date.issued | 2021-05-19 | |
dc.identifier.citation | 3 p. | en_US |
dc.identifier.uri | http://dspace.unimap.edu.my:80/xmlui/handle/123456789/71354 | |
dc.language.iso | ms | en_US |
dc.publisher | Harian Metro | en_US |
dc.subject | Covid 19 | en_US |
dc.subject | Vaksin Covid-19 | en_US |
dc.subject | Pfizer | en_US |
dc.subject | Astrazeneca | en_US |
dc.subject | Campuran vaksin | en_US |
dc.subject | Ujian klinikal | en_US |
dc.subject | Kesan sampingan | en_US |
dc.subject | Institut Kesihatan Carlos II | en_US |
dc.title | Kajian syor campuran Pfizer, Astrazeneca berkesan | en_US |
dc.type | Other | en_US |
Files in this item
This item appears in the following Collection(s)
-
Infographics [3021]